RARE

ULTRAGENYX PHARMACEUTICAL INC

Healthcare | Mid Cap

-$1.40

EPS Forecast

$139.1

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2024-12-31

Proximilar's AI forecasts

EPS Forecast:

-$1.40

Revenue Forecast:

$139.1

EPS Surprise Forecast:

$0.050

Revenue Surprise Forecast:

$5

Post-release price volatility - High

Post-release Overnight Move:

±7.0%

Post-release 1-week Move:

Odds of beating consensus

Probability of beating EPS consensus:

Probability of beating revenue consensus:

Probability of beating both EPS & revs consensus:

Probability of missing both EPS & revs consensus:

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

Beta (β)

Forward Looking Beta (β):

Earnings volatility

EPS standard deviation:

Revenue standard deviation:

Confidence intervals and percentiles

EPS 95th %ile:

Revenue 95th %ile:

$156

EPS 75th %ile:

-$1.30

Revenue 75th %ile:

EPS 25th %ile:

-$1.48

Revenue 25th %ile:

EPS 5th %ile:

Revenue 5th %ile:

$125

Stock's bid-ask spread

Bid-ask per $10K:

Bid-ask per Share: